TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Diameter of vena cava superior
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants With Success
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pharmacokinetic parameters at steady state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Understanding of recent skin excision
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ability to monitor patient respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Patients With Aneurysm Recurrence Post Surgery
Endpoint domain: Mortality/survival
Primary endpoint: Cmax of Diazepam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Composite Score (TCS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety laboratory results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in International Prostate Symptom Score (IPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Visual Analogue Score at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Visual Analogue Score during coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in the respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Seroconversion rate of EV71 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Evaluation of joint function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in General Developmental Assessment (CDIIT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in intestinal microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Progressive Declines in Urine THCCOOH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WOMAC Osteoarthritis Index Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WOMAC Osteoarthritis Index Function Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WOMAC Osteoarthritis Index Stiffness Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects Who Develop an Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Discontinue the Study Drug Due to Adverse Effects
Endpoint domain: Adverse events/effects
Primary endpoint: CRC Screening use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from baseline in investigator-rated ADHD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Azithromycin Ocular Conjunctiva Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Azithromycin Tear Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Stroke Impact Scale (SIS-16)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percent of participants with primary safety endpoint
Endpoint domain: Adverse events/effects
Primary endpoint: Cytokine levels in LPS stimulated blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokine levels in CD3+CD28 stimulated blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokine levels in Poly I:P stimulated blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokine levels in R848 stimulated blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from Baseline Pain at 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Pain at 5 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Blood female hormones level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: sensitivity of HPV methylation testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of HPV methylation testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity of host gene methylation testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of host gene methylation testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: comparison of sensitivity between HPV and host gene methylation testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: comparison of specificity between HPV and host gene methylation testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of acquiring HRME images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children Diagnosed With Active TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Children Achieving Treatment Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children Completing TB Preventive Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy (ACQ score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants evaluated for stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants evaluated for quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants evaluated for nutritional profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of restorations at 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plaque Index (PI) at 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival Index (GI) at 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of pain/discomfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in pain on the VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of surgical site infections
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: sensitivity of coronary DSCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: specificity of coronary DSCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of SF-36 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of Grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of 30 seconds chair stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Change of 6 minutes walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Bone Scan Response (BSR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ageusia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects With a ≥ 2-grade Improvement on Glabellar Lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with G3/G4 treatment-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Time to heal lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sliding frequency of the affected limb during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time patients' surgical position can last
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction level of patients and medical staff
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pelvic Donor Site Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet EoxPL differences in amounts (ng)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUCτ of Lobeglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Css,max of Lobeglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of HbA1c-defined dysglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Local kyphosis (LK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sensitivity of Inter-spinous distance (SD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants With Skin Graft Necrosis
Endpoint domain: Adverse events/effects
Primary endpoint: The Disabilities of the Arm, Shoulder and Hand (QuickDASH) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: complications connected to biopsy and bronchoscopy
Endpoint domain: Adverse events/effects
Primary endpoint: difference in clinical outcome for patients diagnosed by histopathology compared to cytology alone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subcutaneous fat in the limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of CRS-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of improvement in specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Weight Loss (% Change)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in venous ulcer size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean pulmonary artery burst pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of Concentration of HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ROS level in immature granulocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ddQTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cross sectional area of the internal jugular vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Maximal Exercise Capacity (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Skeletal Muscle Perfusion During Exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Skeletal Muscle Mitochondrial Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitreous and serum levels of Fractalkine and VEGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of brain ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Laser-Doppler flowmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean within-participant difference in self-contamination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erythropoietin (EPO) resistance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: noncompliance rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Immediate postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Drinks Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCL-5 Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Learning needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: C-peptide change from baseline to 12 months follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Insulin Adjusted HbA1c change from baseline to 12 months follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Insulin per kg from baseline to 12 months follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Midazolam area under the plasma concentration-time curve (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midazolam maximum observed plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Omeprazole area under the plasma concentration-time curve (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Omeprazole maximum observed plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calories
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Energy Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Relative change of individual salivary cotinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow coma scale after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Relapse of Body Dysmorphic Disorder (BDD) Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Postoperative Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5% reduction in BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5% reduction in waist circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normal T2 * values of the myocardium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effectiveness of Thrombi-Gel in Hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Familial hypercholesterolemia diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetic examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sun Exposure Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sun Exposure Attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sun Exposure Behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Concentration-time profile of antifungals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Suboptimal Surgical Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss in ML
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Biomarkers indicating or excluding invasive Candidiasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Knee flexion and extension strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to perform each motor function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait speed measured during the 6 minutes walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHDRS-IV-Parent Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With Egg Albumin Leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postabsorptive blood cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in cSMS (Combined Symptom and Medication Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of ABT-333
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Ritonavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Plasma Concentration (Tmax) of ABT-450
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palivizumab efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Safety of treatment and the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of side effects or drug intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients requiring higher narcotic support
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rehospitalization for congestive heart failure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from baseline in pixel intensity quantification of fundus autofluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in pixel intensity quantification of flavoprotein autofluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication Adherence - Pill Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication Adherence - Proper Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication Adherence - ASK12
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Constant score assessment of shoulder function and pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Hospitals being able to apply OPAT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of diverticula closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of tuberculosis after transplantation
Endpoint domain: Adverse events/effects
Primary endpoint: Receipt of Brief Intervention for Drug Use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Patients Requiring Medical Intervention for Respiratory Events
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Absence of postoperative Nausea and Vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Number of episodes of myocardial ischaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total time spent by caregivers to complete a defined care area task
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maximum-tolerated dose (MTD) of IONIS-STAT3Rx
Endpoint domain: Adverse events/effects
Primary endpoint: Overall frequency and intensity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep quantity and quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in summary ordinal score on the Short Physical Performance Battery test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Measurement of predefined complications
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of catheter complications
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep apnea severity classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Concentrations of ropivacaine in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Death of the patients
Endpoint domain: Mortality/survival
Primary endpoint: Extent of left atrial stunning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gastric Filling Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of sleep-related breathing disorders
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in PCWP/CVP ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Patients With Vitreous Haze Score of Zero
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Event of all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Experience of self-management of pneumoconiosis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Care-giving experience of family caregivers of pneumoconiosis
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Mean Percent Total Body Weight Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in NIMH Trichotillomania Severity Scale (NIMH-TSS) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes